BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12705785)

  • 1. Antibodies to GM2 ganglioside in neurological disorders.
    Odaka M; Yuki N
    Intern Med; 2003 Mar; 42(3):220-1. PubMed ID: 12705785
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
    Mizutani K; Oka N; Kusunoki S; Kaji R; Kanda M; Akiguchi I; Shibasaki H
    Intern Med; 2003 Mar; 42(3):277-80. PubMed ID: 12705795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies.
    O'Hanlon GM; Veitch J; Gallardo E; Illa I; Chancellor AM; Willison HJ
    Autoimmunity; 2000 Sep; 32(2):133-44. PubMed ID: 11078160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.
    Nakao T; Kon K; Ando S; Miyatake T; Yuki N; Li YT; Furuya S; Hirabayashi Y
    J Biol Chem; 1993 Oct; 268(28):21028-34. PubMed ID: 7691804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
    Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review.
    Silva CT; Silva S; Silva MJ; Almeida AF; Fonseca J; Melo C; Sampaio M; Sousa R
    Clin Pediatr (Phila); 2020 Mar; 59(3):300-304. PubMed ID: 31888351
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-GM2 antibody positive Guillain-Barré syndrome presenting with ataxia in a pediatric patient: An atypical manifestation.
    Deliceo Göbüt E; Us Ö; Işık U
    Brain Dev; 2021 Jun; 43(6):729-733. PubMed ID: 33726944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.
    Cronin S; McNicholas R; Kavanagh E; Reid V; O'Rourke K
    Ir J Med Sci; 2011 Mar; 180(1):255-7. PubMed ID: 21063804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia.
    Vachalová I; Golden V; Heckmann JG
    Clin Neurol Neurosurg; 2014 Jul; 122():131-2. PubMed ID: 24813327
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
    Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome.
    Andersen SM; Ling CC; Zhang P; Townson K; Willison HJ; Bundle DR
    Org Biomol Chem; 2004 Apr; 2(8):1199-212. PubMed ID: 15064799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome following hepatitis E.
    Loly JP; Rikir E; Seivert M; Legros E; Defrance P; Belaiche J; Moonen G; Delwaide J
    World J Gastroenterol; 2009 Apr; 15(13):1645-7. PubMed ID: 19340910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies.
    Kusunoki S
    Am J Med Sci; 2000 Apr; 319(4):234-9. PubMed ID: 10768608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of GM2 ganglioside metabolism in cultured cells.
    Dawson G; Hancock LW; Vartanian T
    Chem Phys Lipids; 1986 Dec; 42(1-3):105-16. PubMed ID: 3549015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae infection and Guillain-Barré syndrome.
    Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
    Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.